CTSO — CYTOSORBENTS CORP
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 73.2% | -45.9% | — | — | — | — |
Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.70 | — | -0.60 | -0.80 | 2 | — |
| Mar 2027 | 0.00 | — | 0.00 | 0.00 | 1 | — |
| Jun 2027 | 0.00 | — | 0.00 | 0.00 | 1 | — |
| Sep 2027 | 0.20 | 5.6× | 0.20 | 0.20 | 1 | — |
| Dec 2027 | -0.20 | — | -0.20 | -0.20 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -4.40 | — | -4.40 | -4.40 | 2 | — |
| Dec 2027 | -0.90 | — | 0.00 | -1.80 | 2 | — |
| Dec 2028 | 0.60 | 7.5× | 0.60 | 0.60 | 1 | — |
| Dec 2029 | 0.80 | 5.6× | 0.80 | 0.80 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 26 SEC-registered investment managers reported holding CTSO (CYTOSORBENTS CORP) in their latest 13F filings, with a combined reported value of $2.47M across 632.62K shares. That is -95.7% by share count (-14.13M shares) versus the previous quarter, while reported value moved -55.5%. Ownership is concentrated: the five largest holders account for 78.8% of reported value and the top ten for 96.2%.
Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 22 trimmed, 28 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of CYTOSORBENTS CORP (CTSO) include Vanguard Group, AVENIR CORP, Royce & Associates, ranked by reported 13F value among the 114 institutional holders on this page.
CTSO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 26 | 632.62K | $2.47M | -95.7% |
| Q2 2026 | 51 | 16.60M | $6.21M | -2.4% |
| Q1 2026 | 50 | 16.47M | $9.32M | -1.7% |
| Q4 2025 | 50 | 16.70M | $10.67M | -0.0% |
| Q3 2025 | 46 | 16.14M | $15.08M | -1.9% |
| Q2 2025 | 42 | 16.28M | $20.54M | -0.9% |
| Q1 2025 | 46 | 16.75M | $16.76M | +10.4% |
| Q4 2024 | 50 | 15.19M | $14.00M | -6.8% |
Over the 8 quarters shown, institutional share counts decreased 96% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+10.4%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 259.09K | $1.01M | 0.12% | Reduce | |
| 94.22K | $367.47K | 0.00% | Reduce | |
| 73.83K | $287.92K | 0.19% | Reduce | |
| 39.53K | $154.15K | 0.02% | Reduce | |
| 31.36K | $122.30K | 0.00% | Reduce | |
| 30.10K | $117.42K | 0.00% | Reduce | |
| 27.49K | $107.22K | 0.00% | Reduce | |
| 25.79K | $100.57K | 0.01% | Reduce | |
| 15.81K | $61.64K | 0.00% | Reduce | |
| 10.42K | $41.67K | 0.00% | Reduce | |
| 8.30K | $32.38K | 0.00% | Reduce | |
| 6.42K | $25.04K | 0.00% | Reduce | |
| 4.20K | $16.39K | 0.00% | Reduce | |
| 1.46K | $5.85K | 0.00% | New | |
| 1.49K | $5.80K | 0.00% | Reduce | |
| 694 | $2.71K | 0.00% | Reduce | |
| 612 | $2.39K | 0.00% | Add | |
| 558 | $2.18K | 0.00% | Reduce | |
| 1.08K | $1.01K | 0.00% | New | |
| 82 | $320 | 0.00% | Reduce | |
| 52 | $203 | 0.00% | Reduce | |
| 26 | $101 | 0.00% | Reduce | |
| 19 | $76 | 0.00% | Reduce | |
| 1 | $4 | 0.00% | New | |
| 1 | $4 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.19M | $1.94M | 0.24% | Reduce | |
| 1.97M | $740.52K | 0.00% | Add | |
| 1.91M | $715.86K | 0.00% | Add | |
| 1.48M | $552.21K | 0.35% | Hold | |
| 1.21M | $453.06K | 0.06% | Reduce | |
| 627.21K | $234.58K | 0.00% | Reduce | |
| 602.06K | $225.24K | 0.00% | New | |
| 602.06K | $225.24K | 0.00% | Reduce | |
| 555.76K | $207.85K | 0.03% | Add | |
| 499.91K | $186.97K | 0.00% | Hold | |
| 316.17K | $118.25K | 0.00% | Add | |
| 172.65K | $64.57K | 0.00% | Hold | |
| 134.84K | $49.99K | 0.00% | Add | |
| 131.02K | $49.00K | 0.00% | Add | |
| 111.66K | $41.76K | 0.00% | Add | |
| 107.61K | $40.25K | 0.00% | Hold | |
| 104.14K | $38.95K | 0.00% | Hold | |
| 100.02K | $37.41K | 0.00% | Reduce | |
| 91.34K | $34.16K | 0.00% | Reduce | |
| 78.46K | $29.34K | 0.01% | Hold | |
| 71.51K | $27.00K | 0.00% | New | |
| 54.32K | $20.31K | 0.00% | Add | |
| 52.20K | $19.52K | 0.00% | New | |
| 50.12K | $18.74K | 0.00% | Add | |
| 48.00K | $17.95K | 0.00% | Hold |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.22M | $2.95M | 0.36% | Hold | |
| 1.88M | $1.06M | 0.00% | New | |
| 1.71M | $966.96K | 0.13% | Reduce | |
| 1.68M | $950.78K | 0.00% | Add | |
| 1.48M | $836.14K | 0.70% | Hold | |
| 782.99K | $443.41K | 0.00% | Add | |
| 707.26K | $400.62K | 0.00% | Add | |
| 549.90K | $311.41K | 0.04% | Reduce | |
| 499.95K | $283.12K | 0.00% | Hold | |
| 313.86K | $177.64K | 0.00% | New | |
| 172.65K | $97.77K | 0.00% | New | |
| 159.29K | $90.21K | 0.00% | Hold | |
| 130.42K | $74.25K | 0.00% | Hold | |
| 115.20K | $65.20K | 0.00% | Hold | |
| 107.75K | $61.02K | 0.00% | Reduce | |
| 104.14K | $58.97K | 0.01% | Hold | |
| 100.72K | $57.04K | 0.00% | Add | |
| 100.17K | $56.73K | 0.00% | Reduce | |
| 92.54K | $52.41K | 0.00% | Hold | |
| 78.46K | $44.43K | 0.02% | Hold | |
| 55.56K | $31.46K | 0.00% | Hold | |
| 48.00K | $27.18K | 0.00% | Hold | |
| 43.95K | $24.89K | 0.00% | Add | |
| 39.12K | $22.14K | 0.00% | Add | |
| 35.57K | $20.14K | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.23M | $3.34M | 0.36% | Add | |
| 2.20M | $1.41M | 0.00% | Hold | |
| 1.85M | $1.19M | 0.16% | Reduce | |
| 1.63M | $1.04M | 0.00% | Add | |
| 1.48M | $943.78K | 0.80% | Add | |
| 770.55K | $492.54K | 0.00% | Add | |
| 612.00K | $391.19K | 0.05% | Reduce | |
| 603.77K | $386.03K | 0.00% | Hold | |
| 499.95K | $319.57K | 0.00% | New | |
| 159.29K | $101.82K | 0.00% | Hold | |
| 149.28K | $95.42K | 0.00% | Add | |
| 148.37K | $95.00K | 0.01% | Add | |
| 130.42K | $83.45K | 0.00% | Hold | |
| 116.48K | $74.45K | 0.00% | Add | |
| 115.27K | $73.66K | 0.00% | Hold | |
| 108.70K | $69.48K | 0.00% | Hold | |
| 104.14K | $66.57K | 0.01% | Hold | |
| 100.12K | $64.00K | 0.00% | Reduce | |
| 92.54K | $59.15K | 0.00% | Add | |
| 83.36K | $53.29K | 0.00% | Reduce | |
| 78.46K | $50.15K | 0.02% | Hold | |
| 55.56K | $35.51K | 0.00% | Hold | |
| 48.00K | $30.68K | 0.00% | Hold | |
| 38.71K | $24.73K | 0.00% | Hold | |
| 35.95K | $22.98K | 0.00% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.08M | $4.75M | 0.49% | Hold | |
| 2.20M | $2.06M | 0.00% | Add | |
| 2.13M | $1.99M | 0.28% | Reduce | |
| 1.60M | $1.49M | 0.00% | Hold | |
| 1.29M | $1.20M | 1.00% | Add | |
| 764.81K | $714.41K | 0.00% | Add | |
| 738.70K | $690.02K | 0.10% | Reduce | |
| 601.45K | $561.98K | 0.00% | Hold | |
| 159.29K | $148.80K | 0.00% | Hold | |
| 134.81K | $125.92K | 0.00% | Add | |
| 130.42K | $122.44K | 0.00% | Hold | |
| 115.20K | $107.60K | 0.00% | Reduce | |
| 112.22K | $105.00K | 0.01% | New | |
| 108.72K | $101.56K | 0.00% | Hold | |
| 107.26K | $100.19K | 0.00% | Add | |
| 104.14K | $97.27K | 0.01% | Hold | |
| 98.22K | $91.75K | 0.00% | Reduce | |
| 91.56K | $85.53K | 0.00% | Hold | |
| 78.46K | $73.29K | 0.03% | Hold | |
| 65.69K | $61.36K | 0.00% | Add | |
| 64.53K | $60.28K | 0.00% | Reduce | |
| 60.55K | $56.56K | 0.00% | Add | |
| 55.56K | $51.90K | 0.00% | New | |
| 48.00K | $44.84K | 0.00% | Hold | |
| 38.70K | $36.15K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.06M | $6.47M | 0.67% | Hold | |
| 2.62M | $3.35M | 0.49% | Reduce | |
| 2.12M | $2.72M | 0.00% | Add | |
| 1.59M | $2.03M | 0.00% | Reduce | |
| 1.25M | $1.60M | 1.46% | Add | |
| 745.61K | $954.38K | 0.00% | Add | |
| 601.45K | $770.06K | 0.00% | Reduce | |
| 746.20K | $673.07K | 0.09% | Reduce | |
| 159.29K | $203.90K | 0.00% | Hold | |
| 131.85K | $168.77K | 0.00% | New | |
| 130.42K | $166.94K | 0.00% | Reduce | |
| 122.33K | $156.59K | 0.00% | Add | |
| 116.64K | $149.30K | 0.00% | Reduce | |
| 108.59K | $138.99K | 0.00% | Reduce | |
| 105.41K | $134.93K | 0.00% | Hold | |
| 104.14K | $133.30K | 0.02% | Hold | |
| 91.56K | $117.20K | 0.00% | Hold | |
| 78.46K | $100.42K | 0.04% | Hold | |
| 70.88K | $90.73K | 0.00% | Hold | |
| 48.00K | $61.44K | 0.00% | Hold | |
| 46.80K | $59.90K | 0.00% | Reduce | |
| 39.07K | $50.02K | 0.00% | Reduce | |
| 28.90K | $36.99K | 0.00% | Add | |
| 28.00K | $35.84K | 0.00% | Hold | |
| 27.44K | $35.13K | 0.00% | Reduce |
New Positions (Q3 2026)
- Nuveen, LLC 1.46K sh · $5.85K
- GLENMEDE TRUST CO NA 1.08K sh · $1.01K
- DANSKE BANK A/S 1 sh · $4
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 602.06K sh · $225.24K
- CIBC Bancorp USA Inc. sold 172.65K sh · $64.57K
- Northern Trust Corp sold 111.66K sh · $41.76K
- RAYMOND JAMES FINANCIAL INC sold 107.61K sh · $40.25K
- NWF Advisory Services Inc. sold 104.14K sh · $38.95K
- Renaissance Technologies sold 100.02K sh · $37.41K
- Key Client Fiduciary Advisors, LLC sold 78.46K sh · $29.34K
- Virtu Financial LLC sold 71.51K sh · $27.00K
- XTX Topco Ltd sold 54.32K sh · $20.31K
- JANE STREET GROUP, LLC sold 52.20K sh · $19.52K
- LPL Financial LLC sold 50.12K sh · $18.74K
- STIFEL FINANCIAL CORP sold 48.00K sh · $17.95K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVENIR CORP | 259.09K | 5.19M | 5.22M | 5.23M | 5.08M | 5.06M | 5.04M | 3.09M | 2.98M | 2.97M | 3.17M | 3.05M | 2.72M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 94.22K | 1.91M | 1.88M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CM Management, LLC | 73.83K | 1.48M | 1.48M | 1.48M | 1.29M | 1.25M | 954.08K | 700.00K | 800.00K | 850.00K | 825.00K | 415.00K | 450.00K | — | — | — | — | — | — | — |
| Skylands Capital, LLC | 39.53K | 1.21M | 1.71M | 1.85M | 2.13M | 2.62M | 3.00M | 2.78M | 2.76M | 2.84M | 2.88M | 3.25M | 2.94M | — | — | — | — | — | — | — |
| BlackRock Inc | 31.36K | 627.21K | 782.99K | 770.55K | 764.81K | 745.61K | 627.30K | 627.30K | 627.30K | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 30.10K | 602.06K | 707.26K | 603.77K | 601.45K | 601.45K | 613.86K | 474.15K | 467.06K | 434.64K | 438.30K | 364.92K | 364.92K | 371.71K | 371.71K | 371.71K | 368.52K | 367.61K | 702.72K | 693.91K |
| Pathstone Holdings, LLC | 27.49K | 499.91K | 499.95K | 499.95K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Sargent Investment Group, LLC | 25.79K | 555.76K | 549.90K | 612.00K | 738.70K | 746.20K | 823.50K | 1.25M | 1.63M | 1.43M | 1.37M | 1.31M | 1.26M | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 15.81K | 316.17K | 313.86K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Neuberger Berman Group LLC | 10.42K | 1.97M | 1.68M | 1.63M | 1.60M | 1.59M | 1.68M | 1.68M | 1.78M | 1.54M | 1.91M | 1.80M | 1.50M | — | — | — | — | — | — | — |
| UBS Group AG | 8.30K | 131.02K | 115.20K | 115.27K | 115.20K | 122.33K | 115.20K | 144.93K | 2.57K | 1.86K | 57 | 2.96K | 197 | 1.12K | 480 | 3.55K | 5.66K | 458 | 3.19K | 11.25K |
| OSAIC HOLDINGS, INC. | 6.42K | 134.84K | 130.42K | 130.42K | 130.42K | 130.42K | 163.75K | 127.22K | 122.42K | — | 25 | 112.71K | 185.31K | — | — | — | — | — | — | — |
| Morgan Stanley | 4.20K | 91.34K | 100.17K | 116.48K | 107.26K | 105.41K | 105.71K | 106.62K | 113.98K | 114.22K | 116.39K | 119.98K | 123.31K | 123.50K | 125.98K | 111.34K | 103.55K | 309.11K | 191.35K | 178.15K |
| Nuveen, LLC | 1.46K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 1.49K | 10.22K | — | 2.17K | 5.61K | 1.54K | 5.50K | 2.10K | 2.98K | 21.70K | 8.02K | 6.16K | 803 | — | — | — | — | — | — | — |
| Vanguard Global Advisers, LLC | 694 | 13.87K | 13.87K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | 612 | 250 | 250 | 730 | 730 | 730 | 250 | 250 | 250 | 453 | 796 | 541 | 525 | 538 | 525 | 520 | 4.51K | 4.55K | 18.24K | 33.02K |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 558 | 11.18K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GLENMEDE TRUST CO NA | 1.08K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Rockefeller Capital Management L.P. | 82 | 1.65K | 1.86K | 2.57K | 1.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CTSO?
As of 2026-Q3, 26 institutional funds reported holding CTSO (CYTOSORBENTS CORP) in SEC 13F filings, with a combined reported value of $2.47M.
How many shares of CTSO do institutions own?
13F filers reported 632.62K shares of CTSO, worth $2.47M in aggregate at the end of 2026-Q3.
Is institutional ownership of CTSO rising or falling?
Share counts moved -95.7% versus the prior quarter — distribution.
Who are the top institutional holders of CTSO?
The largest 13F holders are Vanguard Group, AVENIR CORP, Royce & Associates, VANGUARD CAPITAL MANAGEMENT LLC, Granahan Investment Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of CYTOSORBENTS CORP?
The major shareholders of CYTOSORBENTS CORP (CTSO) by reported 13F value are Vanguard Group, AVENIR CORP, Royce & Associates, VANGUARD CAPITAL MANAGEMENT LLC, Granahan Investment Management, LLC, among 114 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.